TLR2, toll like receptor 2, 7097

N. diseases: 749; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 Biomarker phenotype CTD_human Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. 22178603 2012
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 Biomarker phenotype LHGDN C-Jun NH2 terminal kinase (JNK) is an essential mediator of Toll-like receptor 2-induced corneal inflammation. 18218857 2008
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 Biomarker phenotype LHGDN These results suggest that TLR2 and TLR4 may play a role in aortic valve inflammation and stenosis. 17942642 2008
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 AlteredExpression phenotype LHGDN Taking together, these studies reveal coordinated induction of TLR2 and TLR6 during hypoxia and suggest tissue hypoxia in transcriptional adaptation of innate immune responses during acute infection or inflammation. 18159247 2007
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 Biomarker phenotype LHGDN These observations support the notion of a potential role for activation through TLR-2 and TLR-4 in the inflammation and joint destruction of RA. 17599732 2007
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 Biomarker phenotype RGD We could thus demonstrate that activation of TLR-2 and -6 can induce systemic inflammation in rats accompanied by the classical signs of brain-controlled illness responses. 16154916 2006
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 AlteredExpression phenotype LHGDN Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. 16606450 2006
CUI: C0021368
Disease: Inflammation
Inflammation
0.560 AlteredExpression phenotype LHGDN Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. 16146574 2005
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 AlteredExpression disease BEFREE Exogenous TSLP with Aspergillus led to severe keratitis and worse corneal recovery with higher levels of TLR2, TLR4, IL-6, and IL-8 as well as increased neutrophil infiltration. 30853520 2019
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 Biomarker disease BEFREE Our findings reveal a critical role for the PRRs TLR2 and 9, and their adaptor protein MyD88, in corneal inflammation upon adenovirus infection. 27528076 2017
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 Biomarker disease CTD_human Resveratrol role in Staphylococcus aureus-induced corneal inflammation. 23661603 2013
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 Therapeutic disease RGD This study aims to investigate the effect of targeting TLR2 on Aspergillus fumigatus keratitis in rats. 21647173 2012
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 Biomarker disease BEFREE Toll-like receptor 2 (TLR2) is an essential mediator of corneal inflammation induced by the filarial nematode Onchocerca volvulus, which harbors endosymbiotic Wolbachia bacteria. 19168746 2009
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 AlteredExpression disease BEFREE The Western blot showed the protein expression of TLR2, 4, and 9 was also upregulated in the corneas with F. solani keratitis than that of the healthy corneas. 18398706 2008
CUI: C0022568
Disease: Keratitis
Keratitis
0.550 Biomarker disease BEFREE These findings indicate that S. aureus-induced corneal inflammation is mediated by TLR2 and MyD88 in resident epithelial cells and infiltrating neutrophils. 16926427 2006
CUI: C0035126
Disease: Reperfusion Injury
Reperfusion Injury
0.500 Biomarker disease CTD_human Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways. 25780291 2015
CUI: C0035126
Disease: Reperfusion Injury
Reperfusion Injury
0.500 Biomarker disease RGD Ischemia-reperfusion injury activates innate immunity in rat kidneys. 15912106 2005
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.400 Biomarker disease BEFREE It was positively associated with TLR2 and TLR4 in RA. 31620132 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.400 AlteredExpression disease BEFREE Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome. 31132191 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.400 GeneticVariation disease BEFREE We found associations between polymorphisms in TLR2 (P = 0.018) and TLR4 (P = 0.044) and risk of CRC per se, interactions between intake of red and processed meat (10 g/d) and polymorphisms in TLR1 (P-interaction = 0.032) and TLR10 (P-interaction = 0.026 and 0.036), and intake of cereals (50 g/d) and TLR4 (P-interaction = 0.044) in relation to risk of CRC. 29566186 2018
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.400 GeneticVariation disease BEFREE The aim of this study was to investigate TLR2 (-196 to-174del), TLR4 (Asp299Gly and Thr399Ile) and TLR9 (T1237C and T1486C) gene polymorphisms at risk of colorectal cancer (CRC) development and progression. 29883450 2018
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.400 Biomarker disease BEFREE Moreover, as in the case of other animal intestinal diseases, the protective role of PSA against CRC pathogenesis was also mediated by TLR2.Our results reveal that PSA from <i>B. fragilis</i> plays a protective role against CRC via TLR2 signaling. 30065713 2018
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.400 Biomarker disease BEFREE Taken together, these findings demonstrate that TLR2 plays an important role in colorectal tumorigenesis and may represent a promising therapeutic target in CRC. 29689497 2018
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.400 Biomarker disease BEFREE In this study, we investigated the effect of TLR2-activation on mitochondrial function and bioenergetics in primary RA-synovial fibroblast cells (RASFC), and further determined the role of glycolytic blockade on TLR2-induced inflammation in RASFC using glycolytic inhibitor 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO). 28225071 2017
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.400 Biomarker disease BEFREE Importantly, M2 macrophages derived from HD or patients with RA showed both a decreased ratio of interleukin (IL)-10/IL-6 and IL-10/IL-8 upon stimulation with TLR2 ligand Pam3 compared with TLR4 ligand LPS. 29096690 2017